litlas
Log inCreate account

Peter E. Czabotar

Active 2003–2025

85
Papers
25,339
Citations
58
h-index
84
i10-index

Citations

Citations per year for Peter E. Czabotar1985: 1 citations1990: 1 citations1991: 1 citations1995: 1 citations2004: 3 citations2005: 1 citations2006: 1 citations2007: 77 citations2008: 140 citations2009: 104 citations2010: 163 citations2011: 140 citations2012: 111 citations2013: 201 citations2014: 232 citations2015: 293 citations2016: 283 citations2017: 336 citations2018: 321 citations2019: 1,086 citations2020: 1,347 citations2021: 1,491 citations2022: 1,333 citations2023: 1,030 citations2024: 1,667 citations2025: 886 citations2026: 21 citations1986–1989: no citations, so these years are not shown1992–1994: no citations, so these years are not shown1996–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,788 citing papers, 22.3% of this breakdownUnited States: 2,510 citing papers, 20% of this breakdownAustralia: 707 citing papers, 5.7% of this breakdownGermany: 688 citing papers, 5.5% of this breakdownUnited Kingdom: 641 citing papers, 5.1% of this breakdownFrance: 417 citing papers, 3.3% of this breakdownItaly: 341 citing papers, 2.7% of this breakdownIndia: 291 citing papers, 2.3% of this breakdownJapan: 269 citing papers, 2.2% of this breakdownCanada: 266 citing papers, 2.1% of this breakdownSpain: 241 citing papers, 1.9% of this breakdownSouth Korea: 222 citing papers, 1.8% of this breakdown
0%22.3%Other 25.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology44.5%
  • Medicine36.8%
  • Immunology and Microbiology8.6%
  • Computer Science1.7%
  • Neuroscience1.5%
  • Agricultural and Biological Sciences1.4%
  • Other5.5%

Topics

  • Cell death mechanisms and regulation7.5%
  • Inflammasome and immune disorders3.7%
  • Autophagy in Disease and Therapy3.5%
  • Ferroptosis and cancer prognosis3.4%
  • interferon and immune responses2.1%
  • Mitochondrial Function and Pathology2.1%
  • Other77.7%

Coauthors

All papers

Open in search
  1. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Authors: Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson, John Abrams, Dieter Adam, Patrizia Agostinis, Emad S. Alnemri, Lucia Altucci, Ivano Amelio, David W. Andrews, Margherita Annicchiarico‐Petruzzelli, Alexey V. Antonov, Eli Arama, Eric H. Baehrecke, Nickolai A. Barlev, Nicolás G. Bazán, Francesca Bernassola, Mathieu J.M. Bertrand, Katiuscia Bianchi, Mikhail V. Blagosklonny, Klas Blomgren, Christoph Borner, Patricia Boya, Catherine Brenner, Michelangelo Campanella, Eleonora Candi, Didac Carmona‐Gutiérrez, Francesco Cecconi, Francis Ka-Ming Chan, Navdeep S. Chandel, Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gerald M. Cohen, Marcus Conrad, Juan R. Cubillos‐Ruiz, Peter E. Czabotar, Vincenzo D’Angiolella, Ted M. Dawson, Valina L. Dawson, Vincenzo De Laurenzi, Ruggero De Maria, Klaus‐Michael Debatin, Ralph J. DeBerardinis, Mohanish Deshmukh, Nicola Di Daniele, Francesco Di Virgilio, Vishva M. Dixit, Scott J. Dixon, Colin S. Duckett, Brian David Dynlacht, Wafik S. El‐Deiry, John W. Elrod, Gian María Fimia, Simone Fulda, Ana J. García‐Sáez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Pierre Golstein, Eyal Gottlieb, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Atan Gross, György Hajnóczky, J. Marie Hardwick, Isaac S. Harris, Michael O. Hengartner, Claudio Hetz, Hidenori Ichijo, Marja Jäättelä, Bertrand Joseph, Philipp J. Jost, Philippe Juin, William J. Kaiser, Michael Karin, Thomas Kaufmann, Oliver Kepp, Adi Kimchi, Richard N. Kitsis, Daniel J. Klionsky, Richard A. Knight, Sharad Kumar, Sam W. Lee, John J. Lemasters, Beth Levine, Andreas Linkermann, Stuart A. Lipton, Richard A. Lockshin, Carlos López-Otı́n, Scott W. Lowe, Tom Luedde, Enrico Lugli, Marion MacFarlane, Frank Madeo, Michal Malewicz, Walter Malorni, Gwenola Manic and 69 more - Cell Death and Differentiation 2018 cited by 6,498

  2. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis

    Authors: Peter E. Czabotar, Ana J. García‐Sáez - Nature Reviews Molecular Cell Biology 2023 cited by 601

  3. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

    Authors: Peter E. Czabotar, Guillaume Lessène, Andreas Strasser, Jerry M. Adams - Nature Reviews Molecular Cell Biology 2013 cited by 3,192

  4. The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism

    Authors: James M. Murphy, Peter E. Czabotar, Joanne M. Hildebrand, Isabelle S. Lucet, Jian‐Guo Zhang, Silvia Álvarez-Díaz, Rowena S. Lewis, Najoua Lalaoui, Donald Metcalf, Andrew I. Webb, Samuel N. Young, Leila N. Varghese, Gillian M. Tannahill, Esme C. Hatchell, Ian J. Majewski, Toru Okamoto, Renwick C. J. Dobson, Douglas J. Hilton, Jeffrey J. Babon, Nicos A. Nicola, Andreas Strasser, John Silke, Warren S. Alexander - Immunity 2013 cited by 1,214

  5. Apoptotic cell death in disease—Current understanding of the NCCD 2023

    Authors: Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A. Aaronson, John Abrams, Dieter Adam, Massimiliano Agostini, Patrizia Agostinis, Emad S. Alnemri, Lucia Altucci, Ivano Amelio, David W. Andrews, Rami I. Aqeilan, Eli Arama, Eric H. Baehrecke, Siddharth Balachandran, Daniele Bano, Nickolai A. Barlev, Jiří Bártek, Nicolás G. Bazán, Christoph Becker, Francesca Bernassola, Mathieu J.M. Bertrand, Marco E. Bianchi, Mikhail V. Blagosklonny, J. Magarian Blander, Giovanni Blandino, Klas Blomgren, Christoph Borner, Carl D. Bortner, Pierluigi Bove, Patricia Boya, Catherine Brenner, Petr Brož, Thomas Brunner, Rune Busk Damgaard, George A. Calin, Michelangelo Campanella, Eleonora Candi, Michele Carbone, Didac Carmona‐Gutiérrez, Francesco Cecconi, Francis Ka-Ming Chan, Guoqiang Chen, Quan Chen, Youhai H. Chen, Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gennaro Ciliberto, Marcus Conrad, Juan R. Cubillos‐Ruiz, Peter E. Czabotar, Vincenzo D’Angiolella, Mads Daugaard, Ted M. Dawson, Valina L. Dawson, Ruggero De Maria, Bart De Strooper, Klaus‐Michael Debatin, Ralph J. DeBerardinis, Alexei Degterev, Giannino Del Sal, Mohanish Deshmukh, Francesco Di Virgilio, Marc Diederich, Scott J. Dixon, Brian David Dynlacht, Wafik S. El‐Deiry, John W. Elrod, Kurt Engeland, Gian María Fimia, Claudia Galassi, Carlo Ganini, Ana J. García‐Sáez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Motti Gerlic, Sourav Ghosh, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Georg Häcker, György Hajnóczky, J. Marie Hardwick, Ygal Haupt, Sudan He, David M. Heery, Michael O. Hengartner, Claudio Hetz, David A. Hildeman, Hidenori Ichijo, Satoshi Inoue, Marja Jäättelä, Ana Janic, Bertrand Joseph, Philipp J. Jost, Thirumala‐Devi Kanneganti and 128 more - Cell Death and Differentiation 2023 cited by 351

  6. The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs

    Authors: Sarah T. Diepstraten, Mary Ann Anderson, Peter E. Czabotar, Guillaume Lessène, Andreas Strasser, Gemma L. Kelly - Nature reviews. Cancer 2021 cited by 354

  7. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death

    Authors: Joanne M. Hildebrand, Maria C. Tanzer, Isabelle S. Lucet, Samuel N. Young, Sukhdeep K. Spall, Pooja Sharma, Catia L. Pierotti, Jean‐Marc Garnier, Renwick C. J. Dobson, Andrew I. Webb, Anne Tripaydonis, Jeffrey J. Babon, Mark D. Mulcair, M.J. Scanlon, Warren S. Alexander, Andrew F. Wilks, Peter E. Czabotar, Guillaume Lessène, James M. Murphy, John Silke - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 596

  8. Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2

    Authors: Theresa Klemm, Gregor Ebert, Dale J. Calleja, Cody C. Allison, Lachlan W. Richardson, Jonathan P. Bernardini, Bernadine G.C. Lu, Nathan W. Kuchel, Christoph Grohmann, Y. Shibata, Zhong Yan Gan, James P. Cooney, Marcel Doerflinger, Amanda E. Au, T. Blackmore, Gerbrand J. van der Heden van Noort, Paul P. Geurink, Huib Ovaa, Janet Newman, Alan Riboldi‐Tunnicliffe, Peter E. Czabotar, Jeffrey P. Mitchell, Rebecca Feltham, Bernhard C. Lechtenberg, Kym N. Lowes, Grant Dewson, Marc Pellegrini, Guillaume Lessène, David Komander - The EMBO Journal 2020 cited by 494

  9. Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

    Authors: Piers Blombery, Mary Ann Anderson, Jianan Gong, Rachel Thijssen, Richard W. Birkinshaw, Ella R. Thompson, Charis E. Teh, Tamia Nguyen, Zhen Xu, Christoffer Flensburg, Thomas E. Lew, Ian J. Majewski, Daniel H.D. Gray, David Westerman, Constantine S. Tam, John F. Seymour, Peter E. Czabotar, David C.S. Huang, Andrew W. Roberts - Cancer Discovery 2018 cited by 426

  10. BAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector Proteins

    Authors: Tudor Moldoveanu, Peter E. Czabotar - Cold Spring Harbor Perspectives in Biology 2019 cited by 183

  11. Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations

    Authors: Richard W. Birkinshaw, Jianan Gong, Cindy S. Luo, Daisy Lio, Christine White, Mary Ann Anderson, Piers Blombery, Guillaume Lessène, Ian J. Majewski, Rachel Thijssen, Andrew W. Roberts, David C.S. Huang, Peter M. Colman, Peter E. Czabotar - Nature Communications 2019 cited by 244

  12. Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis

    Authors: Yanxiang Meng, Katherine A. Davies, Cheree Fitzgibbon, Samuel N. Young, Sarah E. Garnish, Christopher R. Horne, Cindy S. Luo, Jean‐Marc Garnier, Lung‐Yu Liang, Angus D. Cowan, André L. Samson, Guillaume Lessène, Jarrod J. Sandow, Peter E. Czabotar, James M. Murphy - Nature Communications 2021 cited by 103

  13. Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax

    Authors: Piers Blombery, Ella R. Thompson, Tamia Nguyen, Richard W. Birkinshaw, Jianan Gong, Xiangting Chen, Michelle McBean, Rachel Thijssen, Thomas Conway, Mary Ann Anderson, John F. Seymour, David Westerman, Peter E. Czabotar, David C.S. Huang, Andrew W. Roberts - Blood 2020 cited by 158

  14. Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis

    Authors: Peter E. Czabotar, Dana Westphal, Grant Dewson, Stephen Ma, Colin Hockings, W. Douglas Fairlie, Erinna F. Lee, Shenggen Yao, A.Y. Robin, Brian J. Smith, David C.S. Huang, Ruth M. Kluck, Jerry M. Adams, Peter M. Colman - Cell 2013 cited by 580

  15. Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis

    Authors: Emma J. Petrie, Jarrod J. Sandow, Annette V. Jacobsen, Brian J. Smith, Michael D. W. Griffin, Isabelle S. Lucet, Weiwen Dai, Samuel N. Young, Maria C. Tanzer, Ahmad Z. Wardak, Lung‐Yu Liang, Angus D. Cowan, Joanne M. Hildebrand, Wilhelmus J. A. Kersten, Guillaume Lessène, John Silke, Peter E. Czabotar, Andrew I. Webb, James M. Murphy - Nature Communications 2018 cited by 193

  16. The regulation of necroptosis by post-translational modifications

    Authors: Yanxiang Meng, Jarrod J. Sandow, Peter E. Czabotar, James M. Murphy - Cell Death and Differentiation 2021 cited by 120

  17. Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis

    Authors: Sarah E. Garnish, Yanxiang Meng, Akiko Koide, Jarrod J. Sandow, Eric Denbaum, Annette V. Jacobsen, Wayland Yeung, André L. Samson, Christopher R. Horne, Cheree Fitzgibbon, Samuel N. Young, Phoebe P. C. Smith, Andrew I. Webb, Emma J. Petrie, Joanne M. Hildebrand, Natarajan Kannan, Peter E. Czabotar, Shohei Koide, James M. Murphy - Nature Communications 2021 cited by 107

  18. The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments

    Authors: Jian‐Guo Zhang, Peter E. Czabotar, Antonia N. Policheni, Irina Caminschi, Soo San Wan, Susie Kitsoulis, Kirsteen M. Tullett, A.Y. Robin, Rajini Brammananth, Mark F. van Delft, Jinhua Lu, Lorraine A. O’Reilly, Emma C. Josefsson, Benjamin T. Kile, Wei Jin Chin, Justine D. Mintern, Maya A. Olshina, Wilson Wong, Jake Baum, Mark D. Wright, David C.S. Huang, Narla Mohandas, Ross L. Coppel, Peter M. Colman, Nicos A. Nicola, Ken Shortman, Mireille H. Lahoud - Immunity 2012 cited by 332

  19. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized

    Authors: Mark F. van Delft, Andrew H. Wei, Kylie D. Mason, Cassandra J. Vandenberg, Lin Chen, Peter E. Czabotar, Simon N. Willis, Clare L. Scott, Catherine L. Day, Suzanne Cory, Jerry M. Adams, Andrew W. Roberts, David C.S. Huang - Cancer Cell 2006 cited by 1,220

  20. Embryogenesis and Adult Life in the Absence of Intrinsic Apoptosis Effectors BAX, BAK, and BOK

    Authors: Francine Ke, Hannah Vanyai, Angus D. Cowan, Alex R. D. Delbridge, Lachlan Whitehead, Stephanie Grabow, Peter E. Czabotar, Anne K. Voss, Andreas Strasser - Cell 2018 cited by 208

  21. Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy

    Authors: Jonathan P. Bernardini, Jason M. Brouwer, Iris K. L. Tan, Jarrod J. Sandow, Shuai Huang, Che A. Stafford, Aleksandra Bankovacki, Christopher D. Riffkin, Ahmad Z. Wardak, Peter E. Czabotar, Michael Lazarou, Grant Dewson - The EMBO Journal 2018 cited by 114

  22. Discovery of a Potent and Selective BCL-X L Inhibitor with in Vivo Activity

    Authors: Zhi‐Fu Tao, Lisa Hasvold, Le Wang, Xilu Wang, Andrew M. Petros, Chang H. Park, Erwin R. Boghaert, Nathaniel D. Catron, Jun Chen, Peter M. Colman, Peter E. Czabotar, Kurt Deshayes, Wayne J. Fairbrother, John A. Flygare, S.G. Hymowitz, Sha Jin, Russell A. Judge, Michael F. T. Koehler, Peter Kovar, Guillaume Lessène, Michael J. Mitten, Chudi Ndubaku, Paul Nimmer, Hans E. Purkey, Anatol Oleksijew, Darren C. Phillips, Brad E. Sleebs, Brian J. Smith, Morey L. Smith, Stephen K. Tahir, Keith G. Watson, Xiao Yu, John Xue, Haichao Zhang, Kerry Zobel, Saul H. Rosenberg, Chris Tse, Joel D. Leverson, Steven W. Elmore, Andrew J. Souers - ACS Medicinal Chemistry Letters 2014 cited by 331

  23. From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors

    Authors: Christopher R. Gardner, Katherine A. Davies, Ying Zhang, Martin Brzozowski, Peter E. Czabotar, James M. Murphy, Guillaume Lessène - Journal of Medicinal Chemistry 2023 cited by 53

  24. The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation

    Authors: Richard W. Birkinshaw, Peter E. Czabotar - Seminars in Cell and Developmental Biology 2017 cited by 224